Bill Title: Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Creates an advisory council on pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections and pediatric acute neuropsychiatric syndrome to advise the Director of Public Health on research, diagnosis, treatment, and education relating to the disorder and syndrome. Sets forth the membership of the council. Designates the Director of Public Health, or his or her designee, as chair of the council. Requires the council, by January 1, 2017 and annually thereafter, to issue a report to the General Assembly with recommendations concerning practice guidelines, mechanisms to increase clinical awareness, outreach to educators and parents, and development of a network of volunteer experts on pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections and pediatric acute neuropsychiatric syndrome.
Spectrum: Moderate Partisan Bill (Democrat 15-3)
Status: (Passed) 2015-08-07 - Public Act . . . . . . . . . 99-0320
[SB1684 Detail]Download: Illinois-2015-SB1684-Chaptered.html
|
| Public Act 099-0320
|
| SB1684 Enrolled | LRB099 10340 JLK 30567 b |
|
|
AN ACT concerning State government.
|
Be it enacted by the People of the State of Illinois,
|
represented in the General Assembly:
|
Section 5. The Department of Public Health Powers and |
Duties Law of the
Civil Administrative Code of Illinois is |
amended by adding Sections 2310-676 and 2310-677 as follows:
|
(20 ILCS 2310/2310-676 new) |
Sec. 2310-676. Advisory council on pediatric autoimmune |
neuropsychiatric disorder associated with streptococcal |
infections and pediatric acute neuropsychiatric syndrome. |
(a) There is established an advisory council on pediatric |
autoimmune neuropsychiatric disorder associated with |
streptococcal infections and pediatric acute neuropsychiatric |
syndrome to advise the Director of Public Health on research, |
diagnosis, treatment, and education relating to the disorder |
and syndrome. |
(b) The advisory council shall consist of the following |
members, who shall be appointed by the Director of Public |
Health within 60 days after the effective date of this |
amendatory Act of the 99th General Assembly: |
(1) An immunologist licensed and practicing in this |
State who has experience treating persons with pediatric |
autoimmune neuropsychiatric disorder associated with |
|
streptococcal infections and pediatric acute |
neuropsychiatric syndrome and the use of intravenous |
immunoglobulin. |
(2) A health care provider licensed and practicing in |
this State who has expertise in treating persons with |
pediatric autoimmune neuropsychiatric disorder associated |
with streptococcal infections and pediatric acute |
neuropsychiatric syndrome and autism. |
(3) A representative of PANDAS/PANS Advocacy & |
Support. |
(4) An osteopathic physician licensed and practicing |
in this State who has experience treating persons with |
pediatric autoimmune neuropsychiatric disorder associated |
with streptococcal infections and pediatric acute |
neuropsychiatric syndrome. |
(5) A medical researcher with experience conducting |
research concerning pediatric autoimmune neuropsychiatric |
disorder associated with streptococcal infections, |
pediatric acute neuropsychiatric syndrome, |
obsessive-compulsive disorder, tic disorder, and other |
neurological disorders. |
(6) A certified dietitian-nutritionist practicing in |
this State who provides services to children with autism |
spectrum disorder, attention-deficit hyperactivity |
disorder, and other neuro-developmental conditions. |
(7) A representative of a professional organization in |
|
this State for school psychologists. |
(8) A child psychiatrist who has experience treating |
persons with pediatric autoimmune neuropsychiatric |
disorder associated with streptococcal infections and |
pediatric acute neuropsychiatric syndrome. |
(9) A representative of a professional organization in |
this State for school nurses. |
(10) A pediatrician who has experience treating |
persons with pediatric autoimmune neuropsychiatric |
disorder associated with streptococcal infections and |
pediatric acute neuropsychiatric syndrome. |
(11) A representative of an organization focused on |
autism. |
(12) A parent with a child who has been diagnosed with |
pediatric autoimmune neuropsychiatric disorder associated |
with streptococcal infections or pediatric acute |
neuropsychiatric syndrome and autism. |
(13) A social worker licensed and practicing in this |
State. |
(14) A representative of the Special Education |
Services division of the State Board of Education. |
(15) One member of the General Assembly appointed by |
the Speaker of the House of Representatives. |
(16) One member of the General Assembly appointed by |
the President of the Senate. |
(17) One member of the General Assembly appointed by |
|
the Minority Leader of the House of Representatives. |
(18) One member of the General Assembly appointed by |
the Minority Leader of the Senate. |
(c) The Director of Public Health, or his or her designee, |
shall be an ex-officio, nonvoting member and shall attend all |
meetings of the advisory council. Any member of the advisory |
council appointed under this Section may be a member General |
Assembly. Members shall receive no compensation for their |
services. |
(d) The Director of Public Health shall schedule the first |
meeting of the advisory council, which shall be held not later |
than 90 days after the effective date of this amendatory Act of |
the 99th General Assembly. A majority of the council members |
shall constitute a quorum. A majority vote of a quorum shall be |
required for any official action of the advisory council. The |
advisory council shall meet upon the call of the chairperson or |
upon the request of a majority of council members. |
(e) Not later than January 1, 2017, and annually |
thereafter, the advisory council shall issue a report to the |
General Assembly with recommendations concerning: |
(1) practice guidelines for the diagnosis and |
treatment of the disorder and syndrome; |
(2) mechanisms to increase clinical awareness and |
education regarding the disorder and syndrome among |
physicians, including pediatricians, school-based health |
centers, and providers of mental health services; |
|
(3) outreach to educators and parents to increase |
awareness of the disorder and syndrome; and |
(4) development of a network of volunteer experts on |
the diagnosis and treatment of the disorder and syndrome to |
assist in education and outreach.
|
(20 ILCS 2310/2310-677 new) |
Sec. 2310-677. Neonatal Abstinence Syndrome Advisory |
Committee. |
(a) As used in this Section: |
"Department" means the Department of Public Health. |
"Director" means the Director of Public Health. |
"Neonatal Abstinence Syndrome" or "NAS" means various |
adverse conditions that occur in a newborn infant who was |
exposed to addictive or prescription drugs while in the |
mother's womb. |
(b) There is created the Advisory Committee on Neonatal |
Abstinence Syndrome. The Advisory Committee shall consist of up |
to 10 members appointed by the Director of Public Health. The |
Director shall make the appointments within 90 days after the |
effective date of this amendatory Act of the 99th General |
Assembly. Members shall receive no compensation for their |
services. The members of the Advisory Committee shall represent |
different racial, ethnic, and geographic backgrounds and |
consist of: |
(1) at least one member representing a statewide |
|
association of hospitals; |
(2) at least one member representing a statewide |
organization of pediatricians; |
(3) at least one member representing a statewide |
organization of obstetricians; |
(4) at least one member representing a statewide |
organization that advocates for the health of mothers and |
infants; |
(5) at least one member representing a statewide |
organization of licensed physicians; |
(6) at least one member who is a licensed practical |
nurse, registered professional nurse, or advanced practice |
nurse with expertise in the treatment of newborns in |
neonatal intensive care units; |
(7) at least one member representing a local or |
regional public health agency; and |
(8) at least one member with expertise in the treatment |
of drug dependency and addiction. |
(c) In addition to the membership in subsection (a) of this |
Section, the following persons or their designees shall serve |
as ex officio members of the Advisory Committee: the Director |
of Public Health, the Secretary of Human Services, the Director |
of Healthcare and Family Services, and the Director of Children |
and Family Services. The Director of Public Health, or his or |
her designee, shall serve as Chair of the Committee. |
(d) The Advisory Committee shall meet at the call of the |
|
Chair. The Committee shall meet at least 3 times each year and |
its initial meeting shall take place within 120 days after the |
effective date of this Act. The Advisory Committee shall advise |
and assist the Department to: |
(1) develop an appropriate standard clinical |
definition of "NAS"; |
(2) develop a uniform process of identifying NAS; |
(3) develop protocols for training hospital personnel |
in implementing an appropriate and uniform process for |
identifying and treating NAS; |
(4) identify and develop options for reporting NAS data |
to the Department by using existing or new data reporting |
options; and |
(5) make recommendations to the Department on |
evidence-based guidelines and programs to improve the |
outcomes of pregnancies with respect to NAS. |
(e) The Advisory Committee shall provide an annual report |
of its activities and recommendations to the Director, the |
General Assembly, and the Governor by March 31 of each year |
beginning in 2016. The final report of the Advisory Committee |
shall be submitted by March 31, 2019. |
(f) This Section is repealed on June 30, 2019.
|
Section 99. Effective date. This Act takes effect upon |
becoming law.
|
